Qingyi Yang

11PUBLICATIONS
45CO-AUTHORS
Deep learningCheminformatics and quantitative structure-activity relationshipsInstrumental methods (excl. immunological and bioassay methods)Computational chemistryVeterinary pharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 26, 2025
Predictive design of crystallographic chiral separation.

Rokas Elijošius, Emma King-Smith, Felix A Faber

|Feb 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease.

Jamison B Tuttle, Christophe Allais, Charlotte M N Allerton

|Apr 30, 2024
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19.

Charlotte M N Allerton, Joel T Arcari, Lisa M Aschenbrenner

|Jan 03, 2024
Probing the chemical 'reactome' with high-throughput experimentation data.

Emma King-Smith, Simon Berritt, Louise Bernier

|Feb 21, 2023
Species differences in plasma protein binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease inhibitor nirmatrelvir.

Siennah R Greenfield, Heather Eng, Qingyi Yang

Pageof 2